The American Journal of Managed Care

06/17/2025

At the 30th European Hematology Association ( ) Congress, experts highlight breakthroughs in treatment, the importance of patient voices, and challenges in making innovations accessible worldwide. Watch our recap!

At the 30th European Hematology Association (EHA) Congress, hematology experts highlight breakthroughs in treatment, the importance of patient voices, and challenges in making innovations accessible worldwide.

06/17/2025

Free Webinar: Reshaping Rx: Navigating 2025 Drug Pricing Policies

Major changes to drug pricing are on the horizon. Are you ready?
Join us on June 26 at 12 PM EDT for a live webinar that will explore the latest federal and state policy developments and their implications for pharma, payers, providers, and patients.

Get expert insights on:
• Recently passed and proposed drug pricing legislation
• Potential challenges and impacts across the health care system
• Strategic considerations for navigating 2025 and beyond

Whether you're in market access, policy, or health care strategy, this is a must-attend session to stay ahead of critical changes. Register now to save your spot: https://hubs.li/Q03sgHw50

06/16/2025

How are bispecific and trispecific antibodies transforming myeloma care? A new AJMC video from ASCO 2025 explores evolving immunotherapy strategies that could reshape outcomes for patients and providers.

We’re also sharing key takeaways from MDA 2025 in a new video, in which experts highlight advances in care for DMD and SMA. In our latest article, we're also looking at how technology could help solve rural health care staffing challenges.

Join us for evidence, expert voices, and what’s next in care.
In the meantime, stay up-to-date: https://hubs.li/Q03scQfm0

06/16/2025

What are the clinical implications of the 5-year outcomes from CheckMate 9LA comparing first-line nivolumab + ipilimumab with chemotherapy vs chemotherapy alone in metastatic ?

Hear from leading experts as they explore the long-term impact of dual immunotherapy-based regimens, highlight key data insights, and share on how these findings are shaping treatment strategies today.

Tune in:

Review and discuss the clinical implications of the five-year outcomes with first-line nivolumab + ipilimumab with chemotherapy vs chemotherapy in patients with metastatic NSCLC in CheckMate 9LA

06/16/2025

At , Ashley Yocum, PhD, highlights how the Beat AML Master Trial advances safe, personalized treatment and expands targeted therapy options for patients with acute myeloid leukemia ( ).

Watch here: https://hubs.li/Q03s7Djr0

06/16/2025

Unaddressed adverse effects, such as , significantly reduce patient confidence in care plans and negatively impact quality of life for those with and , according to Lorna Warwick, CEO of Lymphoma Coalition.

Watch here: https://hubs.li/Q03s7Ct30

06/16/2025

Adolescent and young adult patients with hematological diseases have unique needs that require a multidisciplinary strategy to ensure their mental and sexual well-being during and beyond treatment, clinicians and patients at agreed.

Learn more here: https://hubs.li/Q03s7Gcp0

06/16/2025

The late-breaking abstracts presented on the last day of show “what a vibrant clinical specialty we’re in,” according to session cochair Brian Huntly, PhD.

Learn more here: https://hubs.li/Q03s7Dhc0

06/16/2025

Abstracts presented during the plenary session of spanned from novel drug regimens for and to investigation of leukemias on the molecular and genetic levels.

Learn more here: https://hubs.li/Q03s7CsY0

06/13/2025

shows promise for high-risk patients with acute myeloid leukemia ( ) with specific genetic mutations, demonstrating efficacy with no new safety signals, according to data in posters presented at .

Learn more here: https://hubs.li/Q03r-ScL0

06/13/2025

Merlin Engelke, MS, explains at that an -driven machine learning model was refined and validated internationally to accurately classify acute subtypes from routine laboratory data, offering a potential tool for improving diagnosis worldwide.

Watch here: https://hubs.li/Q03r-MRS0

06/13/2025

At , Dr Adela Perolla told that is rising sharply in due to emotional strain, long hours, and high patient demands, impacting both physician well-being and patient care.

Watch here: https://hubs.li/Q03r-JHV0